MedCity News October 24, 2024
Katie Adams

This week at HLTH, FDA Commissioner Robert Califf discussed the current state of healthcare AI. He talked about some of the qualms he has, such as his worry that AI is worsening health inequities and his concern that providers aren’t capable of validating AI tools’ effectiveness.

This week at the HLTH conference in Las Vegas, FDA Commissioner Robert Califf sat down with John Brownstein, chief innovation officer at Boston Children’s Hospital, to discuss the current state of healthcare AI, as well as his agency’s role in regulating such a dynamic field.

“I don’t need to tell anybody here that the field has exploded. There’s a real challenge in figuring out how to avoid too much regulation in a field where...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, FDA, Govt Agencies, Technology, Trends
Related Articles:
FDA updates definition of 'healthy'
FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients
4 takeaways from the FDA’s first digital health advisory committee
FDA commissioner, a veteran cardiologist, highlights ongoing issues with US healthcare system
FDA commissioner urges health systems to strengthen AI quality oversight

Share This Article